Back
Royalty Pharma PLC Stock Price Chart
Sponsored
RPRX
Sponsored
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Buy
52
RPRX
Royalty Pharma PLC
Last Price:
$29.50
Seasonality Move:
-3.63%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.24 | Buy |
20-day SMA: | 25.52 | Buy |
50-day SMA: | 26.04 | Buy |
200-day SMA: | 27.33 | Buy |
8-day EMA: | 26.61 | Buy |
20-day EMA: | 26.01 | Buy |
50-day EMA: | 26.16 | Buy |
200-day EMA: | 27.37 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 80.93 | Buy |
Chaikin Money Flow: | 5395962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.68 - 26.56) | Buy |
Bollinger Bands (100): | (25.8 - 28.22) | Buy |
Royalty Pharma PLC Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 29.49 while RPRX 8-day simple moving average is 26.24, which is a Buy signal.
-
The stock price of RPRX is 29.49 while Royalty Pharma PLC 20-day SMA is 25.52, which makes it a Buy.
-
Royalty Pharma PLC 50-day simple moving average is 26.04 while RPRX share price is 29.49, making it a Buy technically.
-
RPRX stock price is 29.49 and Royalty Pharma PLC 200-day simple moving average is 27.33, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Buy
52
Royalty Pharma PLC (RPRX)
is a Buy
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a BuyThe current Royalty Pharma PLC [RPRX] share price is $29.49. The Score for RPRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
13.1B
Price in USD:
29.49
Share Volume:
8M
Royalty Pharma PLC 52-Week Range
52-Week High:
31.66
52-Week Low:
24.05
Buy
52
Royalty Pharma PLC (RPRX)
is a Buy
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 29.49 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is not overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 29.49 while RPRX 8-day exponential moving average is 26.61, which is a Buy signal.
-
The stock price of RPRX is 29.49 while Royalty Pharma PLC 20-day EMA is 26.01, which makes it a Buy.
-
Royalty Pharma PLC 50-day exponential moving average is 26.16 while RPRX share price is 29.49, making it a Buy technically.
-
RPRX stock price is 29.49 and Royalty Pharma PLC 200-day simple moving average is 27.37, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.38 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Royalty Pharma PLC is a Buy
-
Royalty Pharma PLC Relative Strength Index (RSI) is 80.93, which suggest Royalty Pharma PLC is overbought
-
The Bollinger Bands (25) for Royalty Pharma PLC is (24.68 - 26.56), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (25.8 - 28.22), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.